Michael Alan Black

Title: Michael Alan Black: Innovator in Cancer Prognostics

Introduction

Michael Alan Black is a notable inventor based in Dunedin, New Zealand. He has made significant contributions to the field of cancer research, particularly in the area of colorectal cancer. With a total of five patents to his name, Black's work focuses on the use of genetic markers to improve cancer prognosis and treatment.

Latest Patents

One of Black's latest patents involves methods for treating colorectal cancer using prognostic genetic markers. This invention relates to prognostic signatures, compositions, and methods for determining the prognosis of cancer in a patient, specifically for colorectal cancer. The invention utilizes genetic markers to predict the prognosis of cancer, allowing for better treatment decisions. It includes methods for predicting the likelihood of long-term survival of a cancer patient, determining treatment regimes, and preparing treatment modalities. Additionally, it encompasses kits and devices designed to facilitate these methods.

Career Highlights

Throughout his career, Michael Alan Black has worked with several prominent organizations. He has been associated with Pacific Edge Limited and the Ludwig Institute for Cancer Research Limited. His work in these institutions has furthered the understanding and treatment of cancer, particularly through innovative approaches to genetic research.

Collaborations

Some of Black's notable coworkers include Jonathan Cebon and Parry John Guilford. Their collaborative efforts have contributed to advancements in cancer research and treatment methodologies.

Conclusion

Michael Alan Black's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to influence the field of oncology and offers hope for better prognostic tools in the future.